QIM
ACOR

Quantitative Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Quantitative Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-199
Closed -$22K – 729
2020
Q1 		$22K Sell
199
-516
-72% -$102K ﹤0.01% 479
2019
Q4 		$174K Buy
715
+352
+97% +$88.8K 0.01% 601
2019
Q3 		$124K Sell
363
-764
-68% -$415K 0.01% 565
2019
Q2 		$1.04M Buy
1,127
+720
+177% +$885K 0.04% 405
2019
Q1 		$648K Buy
407
+304
+295% +$548K 0.04% 455
2018
Q4 		$191K Buy
+103
New +$224K 0.01% 499
2018
Q3 		– Sell
-552
Closed -$1.9M – 940
2018
Q2 		$1.9M Buy
+552
New +$1.69M 0.04% 372
2017
Q2 		– Sell
-188
Closed -$474K – 935
2017
Q1 		$474K Sell
188
-152
-45% -$438K 0.01% 616
2016
Q4 		$767K Buy
+340
New +$808K 0.02% 647
2015
Q3 		– Sell
-74
Closed -$296K – 817
2015
Q2 		$296K Buy
74
+1
+1% +$3.86K 0.04% 323
2015
Q1 		$292K Buy
+73
New +$334K 0.03% 483

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantitative Investment Management's ACOR Position: Q2 2020 in Review

Quantitative Investment Management sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 199 shares — an estimated $22K sold.

Quantitative Investment Management first reported a position in ACOR in Q1 2015 and held it in 11 quarters. The position peaked at $1.9M in Q2 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Quantitative Investment Management reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Quantitative Investment Management sold 199 Acorda Therapeutics shares in Q2 2020, an estimated $22K.
  • Quantitative Investment Management first reported a position in Acorda Therapeutics in Q1 2015 and held it in 11 quarters.
  • Quantitative Investment Management's Acorda Therapeutics position peaked at $1.9M in Q2 2018.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Quantitative Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.